Q: What has happened to PLI?? It was once a recommended stock with 5i but now it is practically a penny stock. Will it survive??
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: The share price is at 28 cents today. Does this not make the company an attractive takeover target. That's about 210 million with no premium and there first FDA drug is just around the corner with a priority voucher attached. I don't think their going broke with Thompson backing.
Q: I know you don't have a crystal ball, but I'm starting to feel that COV may be another RHT. Any thoughts?
Q: Merry Xmas to all
thank you for all the good service you provide us all
What s your opinion on MRK at this price and would you consider it one of the best choices in this field
thank you for all the good service you provide us all
What s your opinion on MRK at this price and would you consider it one of the best choices in this field
Q: May I have your opinion? It seems rather beat down. Possibility of GUD.TO taking them out?
Q: Recently you are not mentioning Covalon as a growth pick. Has your stance changed on the company. Do you think it can breach it's previous high in the next 6 months or so.
Q: Greetings,
Given that we should be "running towards quality" during a downturn , I cannot help but to be tempted by EXE for having more of a short term upside that CSH or SIA.
As long as the dividend is safe, would you agree with me EXE could be viewed as a contrarian purchase?
Cheers
Given that we should be "running towards quality" during a downturn , I cannot help but to be tempted by EXE for having more of a short term upside that CSH or SIA.
As long as the dividend is safe, would you agree with me EXE could be viewed as a contrarian purchase?
Cheers
Q: I have a position of about 4% in JNJ, which is still showing a return on investment of 52% even after last week's plunge. It's in a regular account so is liable for tax. In view of the current litigation concerns, would you recommend that I hang tight and see if it comes back, sell the lot and get out while I am ahead, or hedge and sell half. I am what most people would consider to be elderly - I don't have twenty years to wait for a recovery.
B.
B.
Q: What is the consensus estimate for Q4 revenue and eps please.
Q: I am interested in your opinion on this company - seems to be in the right demographic space and has a good dividend yield currently of 7.263% - how safe is the dividend?
Thanks for any information you have on this
Thanks for any information you have on this
Q: I was wondering if you could give me your thoughts on this stock which is in its very early stages. At what stage would it be wise to consider as an investment or is it something 5 I would be interested in?
Thank you for your time.
Thank you for your time.
Q: Cipher, is hosting an investor webcast today, I am hoping you can report and summarize this event. The question for me regarding this co. is are they growing and I am looking for proof of traction not only in revs but also profits.
Q: Cantor just initiated coverage with a $27 price target on Therapeutics MD saying their three products are under-appreciated and sales will rise faster than expected.
What do you think and is there a short position on this stock?
Thanks.
What do you think and is there a short position on this stock?
Thanks.
Q: why the sudden drop today td had nothing to indicate anything that would warrant a10 percent drop thanks as always
Q: Hi
I have not had time to do the research lately, but what is happening to SIS. I bought it at $16.60 abut a month ago when it was showing good potential and growth. I know that the stock market is turbulent right now, and affecting good companies negatively, but did I miss something important about this company. I bought 300 shares, should I hold on to them or is there something tragic looming on the horizon for SIS.
I have not had time to do the research lately, but what is happening to SIS. I bought it at $16.60 abut a month ago when it was showing good potential and growth. I know that the stock market is turbulent right now, and affecting good companies negatively, but did I miss something important about this company. I bought 300 shares, should I hold on to them or is there something tragic looming on the horizon for SIS.
Q: Morning fellas:
Steven t from Lester who I believe is one of the better stock pickers on BNN including yourselves had this name as a top pick . I know in the past you guys were not as keen. Do u agree with mr t on his assessment and is it a buying oppurtunity.
Thanks
Mark.
Steven t from Lester who I believe is one of the better stock pickers on BNN including yourselves had this name as a top pick . I know in the past you guys were not as keen. Do u agree with mr t on his assessment and is it a buying oppurtunity.
Thanks
Mark.
Q: Would you please give your opinion on these healthcare equities.
Q: Of these two healthcare companies, which do you prefer? WCG dropped a lot in the recent sell off whereas CNC did not? I do own UNH but I'm looking for another for a long term hold?
-
Bausch Health Companies Inc. (BHC $8.68)
-
CRH Medical Corporation (CRH $4.99)
-
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA $16.06)
Q: I am aware that these companies have high debt levels. However, would you view any one of them investable? Or would there be similar companies with better growth prospects?
Thanks for your input!
Thanks for your input!
Q: Aside from JNJ, my US portfolio has no healthcare/biotech stocks. How would you assess these two companies?
Thank you, Team!
P.S. The BNN presentation was very informative!
Thank you, Team!
P.S. The BNN presentation was very informative!